To investigate whether elevated FGF23-FGFR4 signaling might contribute to the cardiac metabolic remodeling observed in CKD, we studied cardiobundles, which are 3-dimensional multicellular cylindrical tissues bioengineered from NRVMs and fibroblasts. The gene discussed is FGF23; the disease is chronic kidney disease.